A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
This study has been completed.
Sponsor:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00284804
First received: January 30, 2006
Last updated: November 27, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2009 |
| Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |